Jung‐Yun Lee
Yonsei University · 604 works · 8,791 citations · h-index 43
Top works
- Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
- Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer
- Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
- Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
- Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
- Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
- Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer
- PO010/#673 A single-arm, phase II study of niraparib and bevacizumab maintenance in patients with platinum-sensitive, recurrent ovarian cancer previously treated with a PARP inhibitor (KGOG 3056/NIRVANA-R)
- Diabetes mellitus as an independent risk factor for lung cancer: A meta-analysis of observational studies
- Trends in gynecologic cancer mortality in East Asian regions
- Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup
- Changes in ovarian cancer survival during the 20 years before the era of targeted therapy
- Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data
- Comparative Effectiveness of Abdominal versus Laparoscopic Radical Hysterectomy for Cervical Cancer in the Postdissemination Era
- ISG15 modification of filamin B negatively regulates the type I interferon‐induced JNK signalling pathway
- Major clinical research advances in gynecologic cancer in 2019
- External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma
- Outcomes of ovarian preservation in a cohort of premenopausal women with early-stage endometrial cancer: A Korean Gynecologic Oncology Group study
- Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer
- Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix